ClinicalTrialsFinder

ESR1 Gene Mutation Clinical Trials in Aschaffenburg

1 recruitingAschaffenburg, Germany

Showing 1–1 of 1 trials

Recruiting
Phase 3

Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i.

HER2-negative Breast CancerAdvanced Breast CancerER Positive Breast Cancer+1 more
MedSIR240 enrolled99 locationsNCT06382948